Conference Menu

Current Event 

Overview
Part I: Therapeutics
Part II: Diagnostics
Register
Short Courses
Hotel & Travel
Part 1 PDF Download
Part 2 PDF Download
Sponsorship & Exhibits
Posters 
Press Pass 
Request Brochure 

Archives 


Download Event PDF
PAY Cover 


Co-Located Events 

Strategic Resource Management &Portfolio Management
November 5-7, 2012 


 Corporate Sponsors  

Analysis Group 

  

 

 

 


Corporate Support Sponsor 

Heron 


Media Partners 

Bio IT Word 

Bentham Science 

Biospace 

eCliniqua Logo 

 Genetic Engineering News 

 GenomeWeb 

HealthEconomics.com 

 nature 

  

 PharmaVoice 

 Science AAAS logo 

The Scientist 


The Evidence Based Reimbursement Summit

Conference Proceeding CD Now Available
  • Speaker Presentations
  • Poster Abstracts
  • and More!
Archived Content

Part I: Generating Evidence for Reimbursement Decisions: Therapeutics

It is important to formulate goals for generating, collecting, and analyzing reimbursement evidence early in product development in order to ensure commercial success of a drug or a biologics. We are witnessing the emergence of a new integrated strategy while the biopharmaceutical industry is partnering up with payers to develop evidence of a product’s validity and utility as well as comparative clinical and cost effectiveness. The inaugural Generating Evidence for Reimbursement Decisions: Therapeutics conference is designed to bring together all major stakeholders in the field of evidence-based reimbursement, clinical development experts, reimbursement and government affairs specialists, health care economists and payers. The conference will be directly followed by Generating Evidence for Reimbursement Decisions: Diagnostics conference.

View Agenda

 

Part II: Generating Evidence for Reimbursement Decisions: Diagnostics 

Achieving commercial success for an IVD product or device is becoming progressively more difficult in the current healthcare environment. The combination of tightening health care budget and launch of a large number of expensive molecular tests creates complications for payers to respond in traditional ways. Comprehensive clinical data and pharma-type clinical trials have increasingly become the condition of getting a test reimbursed. The inaugural Generating Evidence for Reimbursement Decisions: Diagnostics conference is designed to bring together major players the field of evidence-based reimbursement in diagnostics. The conference will be preceded by Generating Evidence for Reimbursement Decisions: Therapeutics conference.

View Agenda

By Series:
By Region: